Greetings and welcome to the Promenade Points newsletter!
We will be sending out monthly updates featuring the latest in software for medical devices, including Promenade and industry news, regulatory updates, and cybersecurity information.
Promenade Software, Inc. is proud to announce the launch of CyberMed∙Cloud 2.0, a complete cloud solution for medical devices and other connected safety critical systems. CyberMed∙Cloud 2.0 meets enterprise demands for performance, administration and security.
CyberMed∙Cloud enables devices innovators to move to market safely, securely, and effectively. Cybersecurity is the core of CyberMed∙Cloud, providing HIPAA and FDA compliant solutions by the application of the NIST Cybersecurity Framework.
Read the full Press Release
Powered by Promenade Software’s CyberMed∙Cloud, DxTerity has expanded their FDA-authorized COVID-19 testing from Enterprise Employers to include at-home testing, available for the public on the Amazon Marketplace.
When Amazon approached DxTerity to provide COVID-19 test kits for sale on Amazon, we at Promenade Software were able to add that online workflow using our telemedicine capabilities within 2 weeks! DxTerity is now able to sell test kits utilizing Amazon's tremendous market reach.
“With CyberMed∙Cloud 2.0 we were able to support our client, DxTerity with their COVID-19 employee screening program and launch of at-home testing, meeting the unprecedented urgency due to the pandemic.” said Frances Cohen, President, Promenade Software, Inc.
Founded in 2013, Promenade Software, Inc. offers a full suite of software development services and solutions specializing in medical devices. Promenade provides expertise in device and mobile app development, regulatory, verification and validation testing, and cybersecurity.
The Promenade Software Team is fully committed to providing the highest-level software services and solutions for your innovations for 2021 and beyond. We are here for you during this dynamic time, prepared to tackle any challenge you may have.
Looking forward to our ongoing partnerships.
Kind Regards,
Frances Cohen
President